Cited 0 times in
Durvalumab + chemotherapy in patients (pts) with advanced EGFR mutation-positive (EGFRm) NSCLC whose disease progressed on first-line (1L) osimertinib: An ORCHARD study interim analysis
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:49:51Z | - |
dc.date.available | 2023-06-02T00:49:51Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194458 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Durvalumab + chemotherapy in patients (pts) with advanced EGFR mutation-positive (EGFRm) NSCLC whose disease progressed on first-line (1L) osimertinib: An ORCHARD study interim analysis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | M-J. Ahn | - |
dc.contributor.googleauthor | C. Baik | - |
dc.contributor.googleauthor | R. García | - |
dc.contributor.googleauthor | J.W. Goldman | - |
dc.contributor.googleauthor | S-W. Kim | - |
dc.contributor.googleauthor | J.S. Lee | - |
dc.contributor.googleauthor | M. Nishio | - |
dc.contributor.googleauthor | S. Ponce | - |
dc.contributor.googleauthor | R. Salgia | - |
dc.contributor.googleauthor | S. Teraoka | - |
dc.contributor.googleauthor | T. Yoshida | - |
dc.contributor.googleauthor | H.A. Yu | - |
dc.contributor.googleauthor | H. Ambrose | - |
dc.contributor.googleauthor | J. Cosaert | - |
dc.contributor.googleauthor | R. Hartmaier | - |
dc.contributor.googleauthor | J. Maidment | - |
dc.contributor.googleauthor | M. Pluta | - |
dc.contributor.googleauthor | I. Okamoto | - |
dc.identifier.doi | 10.1016/j.annonc.2022.02.022 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422001387 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 2 | - |
dc.citation.startPage | S34 | - |
dc.citation.endPage | S35 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 2) : S34-S35, 2022-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.